Aptose Current Ratio from 2010 to 2026
| APS Stock | CAD 2.26 0.01 0.44% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 1.92 | Current Value 1.83 | Quarterly Volatility 6.10880878 |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.4 K, Selling General Administrative of 6.8 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Current Ratio |
Evaluating Aptose Biosciences's Current Ratio across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Current Ratio Growth Pattern
Below is the plot of the Current Ratio of Aptose Biosciences over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Aptose Biosciences' Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 11.27 X | 10 Years Trend |
|
Current Ratio |
| Timeline |
Aptose Current Ratio Regression Statistics
| Arithmetic Mean | 7.30 | |
| Geometric Mean | 4.22 | |
| Coefficient Of Variation | 83.69 | |
| Mean Deviation | 5.00 | |
| Median | 6.40 | |
| Standard Deviation | 6.11 | |
| Sample Variance | 37.32 | |
| Range | 18.1338 | |
| R-Value | (0.23) | |
| Mean Square Error | 37.75 | |
| R-Squared | 0.05 | |
| Significance | 0.38 | |
| Slope | (0.27) | |
| Total Sum of Squares | 597.08 |
Aptose Current Ratio History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Current Ratio, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 1.92 | 1.83 |
Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.